Correction: A novel approach for relapsed/refractory FLT3(mut+)acute myeloid leukaemia: synergistic effect of the combination of bispecific FLT3scFv/NKG2D-CAR T cells and gilteritinib

Detalles Bibliográficos
Autores principales: Li, Ke-xin, Wu, Hui-yang, Pan, Wan-ying, Guo, Meng-qi, Qiu, De-zhi, He, Yan-jie, Li, Yu-hua, Yang, Dong-Hua, Huang, Yu-xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219225/
https://www.ncbi.nlm.nih.gov/pubmed/35739513
http://dx.doi.org/10.1186/s12943-022-01566-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219225/
https://www.ncbi.nlm.nih.gov/pubmed/35739513
http://dx.doi.org/10.1186/s12943-022-01566-0

Ejemplares similares